|
|
|
05.05.26 - 07:12
|
Viatris Names Paul Campbell Interim CFO (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Viatris (VTRS) announced that Theodora 'Doretta' Mistras, Chief Financial Officer, will depart the company for a new professional opportunity. Mistras will remain with the c......
|
|
|
04.05.26 - 22:51
|
Edwards Lifesciences Announces Appointment of CFO (Business Wire)
|
|
|
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced the appointment of Theodora (“Doretta”) Mistras as the company's corporate vice president and chief financial officer (CFO), effective at the end of May. Mistras will succeed Scott Ullem, who announced in October his planned transition from the CFO role.
Mistras joins Edwards from Viatris, where she has served as CFO since March 2024, leading the company's global finance organization and overseeing financial planning, reporting and operational finance across a complex, global business. Prior to Viatris, she was a managing director in healthcare investment banking at Citigroup Global Markets, and earlier in her career held senior leadership roles in healthcare investment banking at Goldman Sachs. Mistras brings decades of healthcare leadership experience helping guide corporate boards and executive teams on corporate finance, strategy and investor relations. She holds a bachelor's degree in international studies from th...
|
|
|
|
|
04.05.26 - 22:33
|
Viatris Announces Chief Financial Officer Transition (PR Newswire)
|
|
|
Theodora "Doretta" Mistras to Depart; Paul Campbell Named Interim CFO PITTSBURGH, May 4, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Theodora "Doretta" Mistras, Chief Financial Officer, will depart the Company for a new professional......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19.03.26 - 14:06
|
Viatris Outlines Long-term Financial Targets (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Viatris (VTRS) said, for combined long-term Targets through 2030, the company expects to deliver 5% to 6% total revenues CAGR, 7% to 8% adjusted EBITDA CAGR, 9% to 10% adjus......
|
|
|
|
|
|
|
|
|
|
|
05.03.26 - 23:45
|
XETR: DIVIDEND/INTEREST INFORMATION - 09.03.2026 - US92556V1061 (XETRA)
|
|
|
Das Instrument VIA US92556V1061 VIATRIS INC. O.N. EQUITY wird cum Dividende/Zinsen gehandelt am 06.03.2026 und ex Dividende/Zinsen am 09.03.2026
The instrument VIA US92556V1061 VIATRIS INC. O.N. EQUITY has its pre-dividend/interest day on 06.03.2026 and its ex-dividend/interest day on 09.03.2026...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
